# PRAMEF15

## Overview
PRAMEF15 is a gene that encodes the protein PRAME family member 15, which is part of the PRAME (Preferentially Expressed Antigen in Melanoma) gene family. This family is recognized for its roles in immunity and reproduction. The PRAMEF15 protein is primarily expressed in reproductive tissues such as the testis and ovary, as well as in early embryonic stages, indicating its potential involvement in reproductive processes and early development. Although the precise molecular functions of PRAMEF15 remain to be fully elucidated, its expression pattern suggests a role in cell proliferation, differentiation, and the maintenance of pluripotency during critical developmental stages (Wang2018Unique; Kern2021The). Additionally, PRAMEF15 has been implicated in various diseases, including facioscapulohumeral dystrophy and acute myeloid leukemia, highlighting its potential as a biomarker and its significance in disease progression (Wong2023Validation; Stiff2024Multiomic).

## Function
PRAMEF15 is a member of the PRAME gene family, which is known for its involvement in immunity and reproduction. In healthy human cells, PRAMEF15 is expressed in reproductive tissues such as the testis and ovary, as well as in early embryonic stages including oocytes, zygotes, and 4-cell stage embryos. This expression pattern suggests a role in reproductive processes and early embryonic development (Kern2021The). 

During the reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs), PRAMEF15 is transiently upregulated in the late stages of naïve reprogramming. It is categorized as an 8-cell-stage-like gene, indicating its potential involvement in transcriptional features associated with totipotency and early embryonic development (Wang2018Unique). 

The specific molecular functions of PRAMEF15 in healthy human cells are not fully elucidated, but its expression in early developmental stages and reproductive tissues implies a role in cell proliferation and differentiation. The protein may be involved in maintaining pluripotency and regulating gene expression during critical stages of development (Wang2018Unique; Kern2021The).

## Clinical Significance
PRAMEF15, a member of the PRAME gene family, has been implicated in various diseases due to its altered expression and mutations. In facioscapulohumeral dystrophy (FSHD), PRAMEF15 is part of a gene signature that distinguishes affected muscle tissue from healthy controls, suggesting its potential as a biomarker for this condition (Wong2023Validation). In the context of acute myeloid leukemia (AML), PRAMEF15 mutations have been identified in a subset of patients, indicating a possible role in the disease's genetic landscape (Stiff2024Multiomic).

The gene is also involved in the transcriptional dynamics during the reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs), where it shows transient up-regulation, highlighting its role in cellular reprogramming processes (Wang2018Unique). Additionally, PRAMEF15 has been identified as one of the top mutant genes in cancer studies, although its specific clinical implications in these contexts are not fully detailed (Liu2021Analysis). These findings suggest that PRAMEF15 may play a significant role in both muscle dystrophy and cancer, potentially affecting disease progression and treatment outcomes.


## References


1. (Wong2023Validation) Validation of the association between MRI and gene signatures in facioscapulohumeral dystrophy muscle: implications for clinical trial design. This article has 0 citations.

[2. (Liu2021Analysis) Lei Liu, Qiuchen Zhao, Chao Cheng, Jingwen Yi, Hongyan Sun, Qi Wang, Weili Quan, Yaqiang Xue, Luguo Sun, Xianling Cong, and Yi Zhang. Analysis of bulk rna sequencing data reveals novel transcription factors associated with immune infiltration among multiple cancers. Frontiers in Immunology, August 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.644350, doi:10.3389/fimmu.2021.644350. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.644350)

[3. (Kern2021The) Chandlar H Kern, Mingyao Yang, and Wan-Sheng Liu. The prame family of cancer testis antigens is essential for germline development and gametogenesis. Biology of Reproduction, 105(2):290–304, April 2021. URL: http://dx.doi.org/10.1093/biolre/ioab074, doi:10.1093/biolre/ioab074. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/biolre/ioab074)

[4. (Stiff2024Multiomic) Andrew Stiff, Maarten Fornerod, Bailee N. Kain, Deedra Nicolet, Benjamin J. Kelly, Katherine E. Miller, Krzysztof Mrózek, Isaiah Boateng, Audrey Bollas, Elizabeth A. R. Garfinkle, Omolegho Momoh, Foluke A. Fasola, Hannah O. Olawumi, Nuria Mencia-Trinchant, Jean F. Kloppers, Anne-Cecilia van Marle, Eileen Hu, Saranga Wijeratne, Gregory Wheeler, Christopher J. Walker, Jill Buss, Adrienne Heyrosa, Helee Desai, Andrea Laganson, Ethan Hamp, Yazan Abu-Shihab, Hasan Abaza, Parker Kronen, Sidharth Sen, Megan E. Johnstone, Kate Quinn, Ben Wronowski, Erin Hertlein, Linde A. Miles, Alice S. Mims, Christopher C. Oakes, James S. Blachly, Karilyn T. Larkin, Bethany Mundy-Bosse, Andrew J. Carroll, Bayard L. Powell, Jonathan E. Kolitz, Richard M. Stone, Cassandra Duarte, Diana Abbott, Maria L. Amaya, Craig T. Jordan, Geoffrey L. Uy, Wendy Stock, Kellie J. Archer, Electra D. Paskett, Monica L. Guzman, Ross L. Levine, Kamal Menghrajani, Debyani Chakravarty, Michael F. Berger, Daniel Bottomly, Shannon K. McWeeney, Jeffrey W. Tyner, John C. Byrd, Nathan Salomonis, H. Leighton Grimes, Elaine R. Mardis, and Ann-Kathrin Eisfeld. Multiomic profiling identifies predictors of survival in african american patients with acute myeloid leukemia. Nature Genetics, October 2024. URL: http://dx.doi.org/10.1038/s41588-024-01929-x, doi:10.1038/s41588-024-01929-x. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41588-024-01929-x)

[5. (Wang2018Unique) Yixuan Wang, Chengchen Zhao, Zhenzhen Hou, Yuanyuan Yang, Yan Bi, Hong Wang, Yong Zhang, and Shaorong Gao. Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (ipscs) at naïve state. eLife, January 2018. URL: http://dx.doi.org/10.7554/elife.29518, doi:10.7554/elife.29518. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.29518)